Azizul Haque - Publications

Medical University of South Carolina, Charleston, SC, United States 
Cancer immunobiology, cell biology, immune regulation, inflammation

41 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Haque A, Capone M, Matzelle D, Cox A, Banik NL. Targeting Enolase in Reducing Secondary Damage in Acute Spinal Cord Injury in Rats. Neurochemical Research. PMID 28508172 DOI: 10.1007/s11064-017-2291-z  0
2016 Aktar S, Jahan M, Alam S, Mohanto NC, Arefin A, Rahman A, Haque A, Himeno S, Hossain K, Saud ZA. Individual and Combined Effects of Arsenic and Lead on Behavioral and Biochemical Changes in Mice. Biological Trace Element Research. PMID 27787814 DOI: 10.1007/s12011-016-0883-0  0
2016 God JM, Haque A. Multiple Defects Impair the HLA Class II Antigen Presentation Capacity of Burkitt Lymphoma. Journal of Clinical & Cellular Immunology. 7. PMID 27747135 DOI: 10.4172/2155-9899.1000e119  0
2016 Capone M, Bryant JM, Sutkowski N, Haque A. Fc Receptor-Like Proteins in Pathophysiology of B-cell Disorder. Journal of Clinical & Cellular Immunology. 7. PMID 27446638 DOI: 10.4172/2155-9899.1000427  0
2016 Haque A, Ray SK, Cox A, Banik NL. Neuron specific enolase: a promising therapeutic target in acute spinal cord injury. Metabolic Brain Disease. PMID 26847611 DOI: 10.1007/s11011-016-9801-6  0
2015 Doonan BP, Haque A. Prostate Cancer Immunotherapy: Exploiting the HLA Class II Pathway in Vaccine Design. Journal of Clinical & Cellular Immunology. 6. PMID 26807308 DOI: 10.4172/2155-9899.1000351  0
2015 Noman AS, Dilruba S, Mohanto NC, Rahman L, Khatun Z, Riad W, Al Mamun A, Alam S, Aktar S, Chowdhury S, Saud ZA, Rahman Z, Hossain K, Haque A. Arsenic-induced Histological Alterations in Various Organs of Mice. Journal of Cytology & Histology. 6. PMID 26740907 DOI: 10.4172/2157-7099.1000323  0
2015 Islam MS, Mohanto NC, Karim MR, Aktar S, Hoque MM, Rahman A, Jahan M, Khatun R, Aziz A, Salam KA, Saud ZA, Hossain M, Rahman A, Mandal A, Haque A, et al. Elevated concentrations of serum matrix metalloproteinase-2 and -9 and their associations with circulating markers of cardiovascular diseases in chronic arsenic-exposed individuals. Environmental Health : a Global Access Science Source. 14: 92. PMID 26637202 DOI: 10.1186/s12940-015-0079-7  0
2015 Chakrabarti M, Das A, Samantaray S, Smith JA, Banik NL, Haque A, Ray SK. Molecular mechanisms of estrogen for neuroprotection in spinal cord injury and traumatic brain injury. Reviews in the Neurosciences. PMID 26461840 DOI: 10.1515/revneuro-2015-0032  0
2015 Samantaray S, Knaryan VH, Shields DC, Cox AA, Haque A, Banik NL. Inhibition of Calpain Activation Protects MPTP-Induced Nigral and Spinal Cord Neurodegeneration, Reduces Inflammation, and Improves Gait Dynamics in Mice. Molecular Neurobiology. 52: 1054-66. PMID 26108182 DOI: 10.1007/s12035-015-9255-6  0
2015 Sambandam Y, Sakamuri S, Balasubramanian S, Haque A. RANK Ligand Modulation of Autophagy in Oral Squamous Cell Carcinoma Tumor Cells. Journal of Cellular Biochemistry. PMID 26095774 DOI: 10.1002/jcb.25255  0
2015 God JM, Cameron C, Figueroa J, Amria S, Hossain A, Kempkes B, Bornkamm GW, Stuart RK, Blum JS, Haque A. Elevation of c-MYC disrupts HLA class II-mediated immune recognition of human B cell tumors. Journal of Immunology (Baltimore, Md. : 1950). 194: 1434-45. PMID 25595783 DOI: 10.4049/jimmunol.1402382  0
2015 Radwan FF, Hossain A, God JM, Leaphart N, Elvington M, Nagarkatti M, Tomlinson S, Haque A. Reduction of myeloid-derived suppressor cells and lymphoma growth by a natural triterpenoid. Journal of Cellular Biochemistry. 116: 102-14. PMID 25142864 DOI: 10.1002/jcb.24946  0
2014 Chakrabarti M, Haque A, Banik NL, Nagarkatti P, Nagarkatti M, Ray SK. Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration. Brain Research Bulletin. 109: 22-31. PMID 25245209 DOI: 10.1016/j.brainresbull.2014.09.004  0
2014 God JM, Zhao D, Cameron CA, Amria S, Bethard JR, Haque A. Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47,000 MW acid labile protein in CD4+ T-cell recognition. Immunology. 142: 492-505. PMID 24628049 DOI: 10.1111/imm.12281  0
2014 Sambandam Y, Townsend MT, Pierce JJ, Lipman CM, Haque A, Bateman TA, Reddy SV. Microgravity control of autophagy modulates osteoclastogenesis. Bone. 61: 125-31. PMID 24463210 DOI: 10.1016/j.bone.2014.01.004  0
2014 Trager N, Smith A, Wallace Iv G, Azuma M, Inoue J, Beeson C, Haque A, Banik NL. Effects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis. Journal of Neurochemistry. 130: 268-79. PMID 24447070 DOI: 10.1111/jnc.12659  0
2013 Trager N, Butler JT, Haque A, Ray SK, Beeson C, Banik NL. The Involvement of Calpain in CD4(+) T Helper Cell Bias in Multple Sclerosis. Journal of Clinical & Cellular Immunology. 4: 1000153. PMID 24707444 DOI: 10.4172/2155-9899.1000153  0
2012 Hossain A, Radwan FF, Doonan BP, God JM, Zhang L, Bell PD, Haque A. A possible cross-talk between autophagy and apoptosis in generating an immune response in melanoma. Apoptosis : An International Journal On Programmed Cell Death. 17: 1066-78. PMID 22847295 DOI: 10.1007/s10495-012-0745-y  0
2012 Radwan FF, Zhang L, Hossain A, Doonan BP, God JM, Haque A. Mechanisms regulating enhanced human leukocyte antigen class II-mediated CD4 + T cell recognition of human B-cell lymphoma by resveratrol. Leukemia & Lymphoma. 53: 305-14. PMID 21854084 DOI: 10.3109/10428194.2011.615423  0
2011 Hathaway JD, Haque A. Insights into the Role of PAX-3 in the Development of Melanocytes and Melanoma. The Open Cancer Journal. 4: 1-6. PMID 24790680 DOI: 10.2174/1874079001104010001  0
2011 Radwan FF, Perez JM, Haque A. Apoptotic and Immune Restoration Effects of Ganoderic Acids Define a New Prospective for Complementary Treatment of Cancer. Journal of Clinical & Cellular Immunology. 4. PMID 23336088 DOI: 10.4172/2155-9899.S3-004  0
2011 God JM, Haque A. Immune Evasion by B-cell Lymphoma. Journal of Clinical & Cellular Immunology. 2. PMID 23336086 DOI: 10.4172/2155-9899.1000e103  0
2011 Hossain A, God JM, Radwan FF, Amria S, Zhao D, Bethard JR, Haque A. HLA class II defects in Burkitt lymphoma: bryostatin-1-induced 17 kDa protein restores CD4+ T-cell recognition. Clinical & Developmental Immunology. 2011: 780839. PMID 22162713 DOI: 10.1155/2011/780839  0
2011 Zhao D, Amria S, Hossain A, Sundaram K, Komlosi P, Nagarkatti M, Haque A. Enhancement of HLA class II-restricted CD4+ T cell recognition of human melanoma cells following treatment with bryostatin-1. Cellular Immunology. 271: 392-400. PMID 21903207 DOI: 10.1016/j.cellimm.2011.08.007  0
2011 Haque A, Banik NL, Ray SK. Molecular alterations in glioblastoma: potential targets for immunotherapy. Progress in Molecular Biology and Translational Science. 98: 187-234. PMID 21199773 DOI: 10.1016/B978-0-12-385506-0.00005-3  0
2011 Smith AW, Doonan BP, Tyor WR, Abou-Fayssal N, Haque A, Banik NL. Regulation of Th1/Th17 cytokines and IDO gene expression by inhibition of calpain in PBMCs from MS patients. Journal of Neuroimmunology. 232: 179-85. PMID 21075457 DOI: 10.1016/j.jneuroim.2010.09.030  0
2010 Johnson BM, Doonan BP, Radwan FF, Haque A. Ganoderic Acid DM: An Alternative Agent for the Treatment of Advanced Prostate Cancer. The Open Prostate Cancer Journal. 3: 78-85. PMID 24790681  0
2010 Doonan BP, Haque A. HLA Class II Antigen Presentation in Prostate Cancer Cells: A Novel Approach to Prostate Tumor Immunotherapy. The Open Cancer Immunology Journal. 3: 1-7. PMID 24163711 DOI: 10.2174/1876401001003010001  0
2010 God JM, Haque A. Burkitt lymphoma: pathogenesis and immune evasion. Journal of Oncology. 2010. PMID 20953370 DOI: 10.1155/2010/516047  0
2009 Norton DL, Haque A. Insights into the Role of GILT in HLA Class II Antigen Processing and Presentation by Melanoma. Journal of Oncology. 2009: 142959. PMID 20016802 DOI: 10.1155/2009/142959  0
2008 Haque A, Banik NL, Ray SK. New insights into the roles of endolysosomal cathepsins in the pathogenesis of Alzheimer's disease: cathepsin inhibitors as potential therapeutics. Cns & Neurological Disorders Drug Targets. 7: 270-7. PMID 18673211 DOI: 10.2174/187152708784936653  0
2008 Amria S, Hajiaghamohseni LM, Harbeson C, Zhao D, Goldstein O, Blum JS, Haque A. HLA-DM negatively regulates HLA-DR4-restricted collagen pathogenic peptide presentation and T cell recognition. European Journal of Immunology. 38: 1961-70. PMID 18506881 DOI: 10.1002/eji.200738100  0
2008 Goldstein OG, Hajiaghamohseni LM, Amria S, Sundaram K, Reddy SV, Haque A. Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma. Cancer Immunology, Immunotherapy : Cii. 57: 1461-70. PMID 18343923 DOI: 10.1007/s00262-008-0483-8  0
2008 Amria S, Cameron C, Stuart R, Haque A. Defects in HLA class II antigen presentation in B-cell lymphomas. Leukemia & Lymphoma. 49: 353-5. PMID 18231926 DOI: 10.1080/10428190701814305  0
2007 Haque A, Hajiaghamohseni LM, Li P, Toomy K, Blum JS. Invariant chain modulates HLA class II protein recycling and peptide presentation in nonprofessional antigen presenting cells. Cellular Immunology. 249: 20-9. PMID 18067883 DOI: 10.1016/j.cellimm.2007.10.005  0
2007 Imam SA, Guyton MK, Haque A, Vandenbark A, Tyor WR, Ray SK, Banik NL. Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients. Journal of Neuroimmunology. 190: 139-45. PMID 17765980 DOI: 10.1016/j.jneuroim.2007.07.016  0
2007 Haque A, Banik NL, Ray SK. Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma. Neurochemical Research. 32: 2203-9. PMID 17676389 DOI: 10.1007/s11064-007-9420-z  0
2007 Haque A, Das A, Hajiaghamohseni LM, Younger A, Banik NL, Ray SK. Induction of apoptosis and immune response by all-trans retinoic acid plus interferon-gamma in human malignant glioblastoma T98G and U87MG cells Cancer Immunology, Immunotherapy. 56: 615-625. PMID 16947022 DOI: 10.1007/s00262-006-0219-6  0
2005 Srinivasan M, Lu D, Eri R, Brand DD, Haque A, Blum JS. CD80 binding polyproline helical peptide inhibits T cell activation. The Journal of Biological Chemistry. 280: 10149-55. PMID 15598660 DOI: 10.1074/jbc.M409521200  0
2004 O'Donnell PW, Haque A, Klemsz MJ, Kaplan MH, Blum JS. Cutting edge: induction of the antigen-processing enzyme IFN-gamma-inducible lysosomal thiol reductase in melanoma cells Is STAT1-dependent but CIITA-independent. Journal of Immunology (Baltimore, Md. : 1950). 173: 731-5. PMID 15240658  0
Show low-probability matches.